AgeX Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. AgeX Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 318% to $142,000. Profit margin reached -10425%. Total operating expenses were $9,931,000.
Profit Margin
| 2017 | 1.40M | -6.58M | -468.66% |
|---|---|---|---|
| 2018 | 1.39M | -7.50M | -537.39% |
| 2019 | 1.72M | -12.38M | -716.67% |
| 2020 | 1.86M | -10.97M | -587.58% |
| 2021 | 144K | -10.22M | -7097.22% |
| 2022 | 34K | -10.67M | -31394.12% |
| 2023 | 142K | -14.80M | -10424.65% |
AGE Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 142K | 34K | 144K | 1.86M | 1.72M | 1.39M | 1.40M |
Cost of revenue | 171K | 13K | 19K | 158K | 244K | 364K | 168K |
Gross profit | -29K | 21K | 125K | 1.71M | 1.48M | 1.03M | 1.23M |
Operating exp. | |||||||
Research and development | 603K | 1.02M | 1.45M | 4.97M | 5.90M | 6.63M | 5.78M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 9.93M | 6.99M | 8.16M | 12.38M | 14.04M | 12.27M | 9.65M |
Operating income | -9.96M | -6.97M | -8.03M | -10.67M | -12.55M | -11.24M | -6.66M |
Other income (expenses), net | -4.85M | -3.54M | -543K | 272K | 323K | 3.39M | 1.78M |
Income before tax | -14.81M | -10.52M | -8.58M | -11.12M | -12.23M | -7.73M | -6.63M |
Income tax expense | -8K | 152K | 1.63M | -150K | 148K | 3.51M | -1.79M |
Net income | -14.80M | -10.67M | -10.22M | -10.97M | -12.38M | -7.50M | -6.58M |
Earnings per share | |||||||
Basic EPS | -13.72 | -9.89 | -9.49 | -10.25 | -11.69 | -7.56 | -6.46 |
Diluted EPS | -13.72 | -9.89 | -9.49 | -10.25 | -11.69 | -7.56 | -6.46 |
| Data source | Data source | Data source | Data source | Data source | Data source |